Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease
- 28 February 1995
- journal article
- clinical trial
- Published by Elsevier BV in Gastroenterology
- Vol. 108 (2), 345-349
- https://doi.org/10.1016/0016-5085(95)90059-4
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Oral mesalazine (5‐aminosalicylic acid; Asacol) for the prevention of post‐operative recurrence of Crohn's diseaseAlimentary Pharmacology & Therapeutics, 1994
- Early mucosal changes in Crohn's disease.Gut, 1993
- Oral 5-aminosalicylic acid (Asacol) in the maintenance treatment of Crohn's diseaseGastroenterology, 1992
- Natural course of Crohn's disease after ileocolic resection: endoscopically visualised ileal ulcers preceding symptoms.Gut, 1992
- Predictability of the postoperative course of Crohn's diseaseGastroenterology, 1990
- Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.BMJ, 1989
- Endoscopic Lesions in Crohn's Disease early after Ileocecal ResectionEndoscopy, 1988
- Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery.Gut, 1984